Effect of Tredaptive on Serum Lipoproteins, Lipoproteins Metabolism, Oxidative Stress and HDL Antioxidant Function.
Phase of Trial: Phase IV
Latest Information Update: 11 Nov 2014
At a glance
- Drugs Niacin/laropiprant (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 11 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Feb 2012 Status changed from recruiting to active, no longer recruiting United Kingdom Clinical Research Network record.
- 24 Jan 2012 United Kingdom Clinical Research Network record reports accrural to date changed from 92% to 100%.